HEPATITIS B & C: THE SILENT EPIDEMICS THREATENING LIVER HEALTH WORLDWIDE
BY OWOLABI OLUWADARA
As the world observes World Hepatitis Awareness Month this July, health experts are drawing attention to the ongoing public health crisis posed by Hepatitis B and C—two viral infections that continue to silently damage millions of lives, particularly in developing nations like Nigeria.
Both Hepatitis B (HBV) and Hepatitis C (HCV) primarily affect the liver, often without showing symptoms until significant damage has been done. According to the World Health Organization (WHO), over 350 million people globally are living with chronic hepatitis B or C, and a significant number of them are unaware of their infection status.
Hepatitis B is caused by the Hepatitis B virus, which is transmitted through contact with infected blood, semen, or other body fluids. This can occur through unprotected sex, sharing of needles or sharp instruments, unscreened blood transfusions, or from an infected mother to her child at birth. It can be acute (short-term) or become chronic, leading to liver inflammation, cirrhosis, liver failure, or liver cancer. Fortunately, hepatitis B is preventable through a safe and effective vaccine that is widely available and recommended for infants and high-risk adults.
Hepatitis C, on the other hand, is caused by the Hepatitis C virus and is primarily spread through blood-to-blood contact, especially via injection drug use, unsafe medical practices, and poorly screened blood products. Unlike hepatitis B, hepatitis C infection is more likely to become chronic, and while no vaccine exists, there are highly effective antiviral medications that can cure more than 95% of chronic cases within 8–12 weeks of treatment.
Despite the severity of these infections, both forms of hepatitis are often called “silent killers” because symptoms typically do not appear until advanced stages of liver damage have occurred. These symptoms may include:
Persistent fatigue
Jaundice (yellowing of skin and eyes)
Abdominal pain
Dark urine
Nausea or vomiting
Loss of appetite and unexplained weight loss
Without early detection and intervention, chronic hepatitis can remain undiagnosed for years, gradually leading to irreversible damage.
Risk factors for hepatitis B and C include:
Multiple sexual partners
Sharing needles or razors
Unsafe tattooing or body piercing
Living with someone infected
Exposure in healthcare settings without proper infection control
To combat the spread and impact of hepatitis, experts recommend:
Universal infant vaccination for hepatitis B
Routine testing and screening, especially for high-risk groups
Public education campaigns to reduce stigma and promote safe practices
Improved access to treatment, particularly in rural or low-resource communities
